Ameloblastoma of the mandible involving an autogenous bone graft

Bianchi, Silvio Diego; Tarello, F; Polastri, F; Valente, Guido

doi:10.1016/s0278-2391(98)90768-6

Cited by 20 publications

(6 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…16,19,20 Continual or segmental type resection, including the lower borders of the mandible in case the latter is affected by the tumor, must always be followed to prevent the autogenous bone graft used for subsequent reconstruction from becoming affected by a recurrence of the neoplasm. 21,22 The lower border of the mandible can be preserved, facilitating subsequent reconstruction, only in cases where it has not been affected by the neoplasm. 15,23,24 In cases where the lower border must be removed during the resection, a reconstructive titanium plate can be used in the subsequent reconstruction of the large surgical deficit to stabilize the continuity of the residual bony fragments and removed after approximately 4 to 6 months once osteointegration of the autogenous bone graft with the surrounding bone is attained, thus ensuring optimal functional and aesthetic results.…”

Section: Discussionmentioning

confidence: 99%

Mandibular Ameloblastoma: Analysis of Surgical Treatment Carried Out in 60 Patients Between 1977 and 1998

Becelli

Carboni

Cerulli

et al. 2002

Journal of Craniofacial Surgery

107

View full text Add to dashboard Cite

Ameloblastoma, a benign tumor of odontogenic type, represents 10% of all tumors of the jawbone. It is localized in the mandible in 80% of cases and in the upper jaw in the remaining 20%. In every case, the selection of the surgical treatment to be applied must consider some fundamental elements, including the age and general state of health of the patient, the clinicopathological variant, and the localization and extent of the tumor. In addition, it is necessary to evaluate whether the neoplasm to be treated is a primitive lesion or a recurrence. Although ameloblastoma has relative histological characteristics of benignity, this neoplasm has a high percentage of local recurrence and possible malignant development when treated inadequately. The aim of this study was to carry out a follow-up of 60 patients treated for ameloblastoma of the mandible between 1977 and 1998, analyzing the problems faced in removing this benign neoplasm and those concerning reconstruction of the surgical defect.

show abstract

Section: Discussionmentioning

confidence: 99%

Mandibular Ameloblastoma: Analysis of Surgical Treatment Carried Out in 60 Patients Between 1977 and 1998

Becelli

Carboni

Cerulli

et al. 2002

Journal of Craniofacial Surgery

107

View full text Add to dashboard Cite

show abstract

“…"solid/multicystic" was dropped because it has no biologic signi cance, but its clinical and radiographic features sometimes was unique [1]. Records in literatures [5][6][7][8][10][11][12][13][14][15][16][17][18][19][20][21][22][23] (table 1)among 25 patients which are about 10 patients graft bone CT showed multicystic [6-8, 12, 15, 18, 19, 21, 22]. Only 12 patients showed the pathological ndings, 6 showed acanthomatous ameloblastoma [5-8, 12, 17, 18, 21, 22].…”

Section: Discussionmentioning

confidence: 99%

Recurrence of ameloblastoma in an autogenous bone graft 10 years after initial operation: A case report and literature review

Wu¹,

Yan²,

Han³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Ameloblastoma is an asymptomatic locally invasive slow-growing odontogenic epithelial tumor. it is rare that the tumor developing in the autogenous bone graft.Case presentation: This report describes a case of ameloblastoma recurrence in an autogenous iliac bone graft 10 years after initial operation in a 37-year-old female who had a history of partial mandibulectomy + left iliac bone graft for ameloblastoma. In 2016 year, the patient was therefore admitted to our hospital for a second surgery, In 2017, 2018, 2019 after the second surgery, radiograph examination showed no recurrence after the surgery.Conclusions: Awareness of the concept of tumor-free operation, extensively resect the affected bone and soft tissue may help in ameloblastoma recurrence, Pathological diagnosis and long-term regular follow-up visits should help improve long-term outcome

show abstract

“…In the present case, no sensitive postoperative deficit was produced after bone harvesting. Complete resection followed by rehabilitation by means of a bone graft does not eliminate the possibility of tumor relapse, which (as various Authors have affirmed) can affect the graft (24,25). This is explained by the remnants of ameloblastoma, which can infiltrate the graft.…”

Section: Figurementioning

confidence: 99%

Unicystic Ameloblastoma: Rehabilitation With Chin Graft Harvested and Implant-Supported Fixed Prosthesis

Sanz-Alonso

Martínez-Rodríguez

Martín-Arés

et al. 2017

ORL

View full text Add to dashboard Cite

SUMMARYObjective. The objective is to present a clinical case of a 38-year-old male with a maxillary unicystic ameloblastoma treated by means of tumor block resection followed by chin-harvested graft placement in order to place two dental implants for esthetic and functional rehabilitation. Methods. Ameloblastoma is a benign odontogenic tumor characterized by local aggression and a high rate of recurrence; the latter partly depends on how it is treated. Complete resection of the tumor, which usually prevents recurrence, produces bone defects of varying size that must be reconstructed later on. In most cases this is done using bone grafts and implant-supported prostheses. Grafts harvested from the chin are relatively easy to obtain and enjoy a fairly uneventful post-operative with few complications; they are suitable for cases in which the defect generated by resection is of small size.Results. Functional and esthetic rehabilitation and the tumor has not relapsed during a 7-year follow-up. Conclusion. Tumor block resection followed by chin-harvested graft placement and dental implants is a safe treatment for patients with unicystic ameloblastoma.

show abstract

Ameloblastoma of the mandible involving an autogenous bone graft

Cited by 20 publications

References 10 publications

Mandibular Ameloblastoma: Analysis of Surgical Treatment Carried Out in 60 Patients Between 1977 and 1998

Mandibular Ameloblastoma: Analysis of Surgical Treatment Carried Out in 60 Patients Between 1977 and 1998

Recurrence of ameloblastoma in an autogenous bone graft 10 years after initial operation: A case report and literature review

Unicystic Ameloblastoma: Rehabilitation With Chin Graft Harvested and Implant-Supported Fixed Prosthesis

Contact Info

Product

Resources

About